 REHOVOT, Israel, Oct. 16, 2019 PRNewswire -- CollPlant CLGN, a regenerative medicine company, today announced the Companys Chief Executive Officer Yehiel Tal will present at the Dawson James 5th Annual Small Cap Growth Conference on Tuesday, October 29, 2019 at 1:10 p.m. ET. Mr. Tal will provide an overview of the Companys business, including in the fields of medical aesthetics including breast implants, and 3D bioprinting of tissues and organs. 